Tüm alıştırma soruları

4736 soru

Soru 2761Soru →

A 65-year-old man with metastatic prostate cancer presents to the palliative care clinic with severe, constant lower back and pelvic pain. He is currently opioid-naive, and his pain is poorly controlled despite maximum scheduled doses of nonsteroidal anti-inflammatory drugs (NSAIDs). An evaluation confirms the pain is primarily nociceptive secondary to osseous metastases. The physician decides to initiate strong opioid therapy.

Arrange the following steps in the most appropriate chronological sequence for safely establishing and optimizing a long-term opioid regimen for this opioid-naive patient, from initial prescribing to long-term maintenance.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence begins with initiating an immediate-release opioid alongside a bowel regimen, followed by calculating the total daily requirement once stable. This requirement is then converted to an extended-release formulation, supplemented with a proportionally calculated breakthrough dose, and finally, followed by long-term monitoring for toxicity.
The established standard of care for initiating strong opioids in opioid-naive patients involves safely titrating with short-acting medications, establishing a reliable 24-hour requirement, converting to a long-acting maintenance dose, adding an appropriate breakthrough pain regimen, and continually monitoring for long-term toxicity.

Adım Adım Çözüm

1
Select the initial prescribing step for an opioid-naive patient.
Initiate an immediate-release opioid to safely titrate analgesia and concurrently start a prophylactic bowel regimen.
Starting with extended-release opioids in naive patients risks fatal respiratory depression. Immediate-release formulations allow safe titration. Constipation prophylaxis is mandatory from day one.
2
Determine the necessary calculation after achieving initial pain control.
Calculate the total daily dose of the immediate-release opioid consumed over a 24- to 48-hour period of stable pain control.
To transition to long-acting therapy, the physician must first establish the patient's actual 24-hour baseline requirement based on their as-needed usage.
3
Select the step for establishing long-term baseline analgesia.
Convert the calculated total daily opioid requirement into a scheduled, extended-release opioid formulation.
Consolidating the daily requirement into an extended-release medication provides consistent round-the-clock pain relief and prevents the patient from having to wake up frequently to take medication.
4
Identify the step to manage incidental or flare-up pain on a maintenance regimen.
Calculate and prescribe an as-needed, immediate-release opioid for breakthrough pain based on the new extended-release dose.
Breakthrough pain is common despite adequate baseline analgesia. A rescue dose is standardly calculated at 10% to 20% of the total daily extended-release dose.
5
Select the long-term maintenance step.
Monitor during maintenance therapy for signs of opioid-induced neurotoxicity requiring potential opioid rotation.
Over time, high doses or declining renal function can cause toxic metabolite accumulation (e.g., from morphine), leading to neurotoxicity that requires rotating to a different opioid.

Anahtar Kavram

The safe initiation of strong opioids in naive patients requires starting with short-acting agents to determine the true daily requirement, followed by conversion to long-acting agents with a calculated supplemental breakthrough dose.
Tahmini Süre:1m 30s
Soru 2762Soru →

A 48-year-old man presents to the emergency department with a 1-day history of right-sided pleuritic chest pain. He has no significant past medical history and takes no medications. He does not smoke or use illicit substances. His temperature is 37.0°C (98.6°F), blood pressure is 128/82 mm Hg, pulse is 88/min, and respiratory rate is 16/min. Pulse oximetry shows 98% on room air. Physical examination reveals clear lungs, normal heart sounds, and no lower extremity edema or calf tenderness. Laboratory studies are notable for a high-sensitivity troponin T of < 0.01 ng/mL and an N-terminal pro-B-type natriuretic peptide (NT-proBNP) of 60 pg/mL (normal: < 125 pg/mL). Renal function is normal. A computed tomography pulmonary angiogram demonstrates a segmental pulmonary embolism in the right lower lobe. The right-to-left ventricular diameter ratio is 0.8. The patient is accompanied by his wife, and they live in an apartment 10 minutes from the hospital. He demonstrates clear understanding of his diagnosis. Which of the following is the most appropriate disposition and initial management plan for this patient?

Cevabı ve açıklamayı göster

Cevap: Discharge home with a prescription for a direct oral anticoagulant

Cevap

The most appropriate disposition is to discharge the patient home with a prescription for a direct oral anticoagulant.
The correct disposition is discharging the patient home with a prescription for a direct oral anticoagulant (DOAC). This patient presents with a newly diagnosed acute pulmonary embolism (PE) but falls strictly into the 'low risk' category. He is hemodynamically stable, requires no supplemental oxygen, and exhibits no objective evidence of right ventricular (RV) strain or myocardial injury (normal troponin, normal NT-proBNP, and an RV/LV diameter ratio < 0.9). Furthermore, he has excellent psychosocial factors: a supportive spouse, close proximity to the hospital, and good healthcare literacy. According to current American College of Chest Physicians (ACCP) and European Society of Cardiology (ESC) guidelines, patients meeting these criteria (e.g., Pulmonary Embolism Severity Index Class I-II or Hestia criteria negative) should be discharged directly from the emergency department with a DOAC (such as apixaban or rivaroxaban) to avoid unnecessary hospitalization, reducing the risk of nosocomial infections and healthcare costs.

Adım Adım Çözüm

1
Evaluate the patient's hemodynamic status based on vital signs.
Blood pressure is 128/82 mm Hg, pulse is 88/min, and oxygen saturation is 98% on room air.
Stable vital signs rapidly rule out massive pulmonary embolism, which would strictly require intensive care unit admission and potential thrombolysis.
2
Assess for signs of right ventricular strain or myocardial injury.
Troponin T is undetectable, NT-proBNP is within normal limits, and the CT scan shows a normal RV/LV ratio (0.8).
Absence of RV strain and myocardial necrosis categorizes the event as a low-risk (rather than submassive/intermediate-risk) pulmonary embolism.
3
Calculate objective risk stratification (e.g., Pulmonary Embolism Severity Index - PESI).
The patient is under 50, has no comorbidities, and has normal vitals, placing him in PESI Class I (very low risk).
Validated scoring systems are required to legally and medically justify discharging a patient with a potentially fatal condition from the emergency department.
4
Determine functional, social, and logistical capacity for outpatient care.
The patient lives closely to the hospital, has an engaged spouse, understands the diagnosis, and has primary care access.
Even low-risk patients cannot be safely discharged if they lack the cognitive or social resources to adhere to anticoagulation therapy or return if symptoms worsen.

Anahtar Kavram

Patients with acute pulmonary embolism who are hemodynamically stable, have no right ventricular strain, and possess good psychosocial support should be safely discharged home from the emergency department on a direct oral anticoagulant.
Soru 2763Soru →

A 68-year-old man is hospitalized with a severe exacerbation of chronic obstructive pulmonary disease. Despite maximal medical therapy and noninvasive positive pressure ventilation, his respiratory status continues to deteriorate. Arterial blood gas analysis reveals a PaCO2 of 88 mm Hg and a PaO2 of 52 mm Hg. The patient is now obtunded, opening his eyes only to painful stimuli, and is unable to communicate his wishes. The intensive care team determines that endotracheal intubation and mechanical ventilation are indicated to preserve his life.

The patient's electronic medical record contains a valid advance directive completed one year ago. The document explicitly names his eldest son as his healthcare proxy and states a firm desire to avoid mechanical ventilation under any circumstances. The patient's wife, who has been married to him for 40 years and is present at the bedside, tearfully demands that the team intubate him immediately, stating, "I am his wife, and I cannot lose him today. Do everything you can." The son, who is contacted by telephone, states, "My father was very clear with me. He would never want to live on a machine. Please keep him comfortable."

Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Withhold intubation and initiate symptom-directed palliative care based on the son's decision

Cevap

Withhold intubation and initiate symptom-directed palliative care based on the son's decision.
The correct answer acknowledges that the patient lacks clinical capacity to make his own medical decisions due to his obtunded state and severe hypercapnia. In this situation, the primary decision-maker is the designated healthcare proxy named in a valid advance directive. The son has been legally appointed to this role and is expressing decisions consistent with the patient's documented wishes. The medical team must honor the proxy's decision to withhold intubation and transition to palliative care, prioritizing patient autonomy over the conflicting wishes of the spouse.

Adım Adım Çözüm

1
Assess the patient's clinical capacity to make medical decisions.
The patient is obtunded, responding only to pain, and cannot communicate.
To determine if the patient can currently direct their own medical care or if a surrogate decision-maker is required.
2
Identify the legally authorized decision-maker for the incapacitated patient.
The eldest son is the designated healthcare proxy documented in a valid advance directive.
A legally appointed proxy supersedes all other family members, including a spouse, in the surrogate hierarchy, regardless of who is physically present.
3
Determine the appropriate clinical intervention based on the proxy's directive.
Intubation is withheld, and the team transitions to palliative care.
The proxy's decision reflects the patient's explicitly documented wishes. The medical team is ethically and legally bound to honor this decision despite the spouse's objections.

Anahtar Kavram

Surrogate decision-making hierarchy and the supremacy of designated healthcare proxies
Soru 2764Soru →

A 62-year-old woman presents to the clinic for routine follow-up of her anticoagulation therapy. She has a history of a mechanical mitral valve replacement and has been maintained on warfarin. Her international normalized ratio (INR) has historically been stable between 2.5 and 3.5. Today, her INR is 1.4. When asked about any changes to her diet or medications, the patient reluctantly admits that she started taking a St. John's wort supplement three weeks ago to help with mild depressive symptoms following the death of her pet. She states defensively, "Please don't tell me to stop taking it. It's natural, it makes me feel so much better, and I hate being reliant on all these synthetic chemicals from the pharmacy."

Which of the following is the most appropriate initial response by the physician?

Cevabı ve açıklamayı göster

Cevap: It sounds like you have been going through a difficult time; can you tell me more about how this supplement has been helping you?

Cevap

The most appropriate initial response is to validate the patient's emotional distress and explore her experience with the supplement by saying, "It sounds like you have been going through a difficult time; can you tell me more about how this supplement has been helping you?"
The correct answer utilizes patient-centered communication to build a therapeutic alliance. The patient is exhibiting resistance and skepticism toward traditional medications while experiencing a vulnerable emotional state due to grief. According to principles of effective patient counseling, the most appropriate initial step is to explore her perspective and validate her distress. Asking an open-ended question about her experience demonstrates empathy and avoids triggering further defensiveness. Once the patient feels heard and respected, the physician can transition into a shared decision-making discussion regarding the dangerous pharmacokinetic interaction between St. John's wort (a potent CYP450 inducer) and warfarin, and then explore safer, evidence-based alternatives for her depressive symptoms.

Adım Adım Çözüm

1
Analyze the patient's clinical situation and current attitude.
The patient has a subtherapeutic INR due to taking St. John's wort (a CYP450 inducer that increases warfarin metabolism). She is grieving, defensive about her choice, and resistant to stopping the supplement.
Understanding both the medical risk and the patient's psychosocial state is required to formulate an effective counseling strategy.
2
Determine the immediate goal of the encounter.
Before the physician can successfully educate the patient about the drug interaction and convince her to stop the supplement, they must lower her defensiveness and build a therapeutic alliance.
Information dump or coercive instructions given to a defensive patient typically result in non-adherence and damage the physician-patient relationship.
3
Select the communication strategy that best achieves this goal.
Using open-ended exploration and empathy (e.g., utilizing the NURSE protocol) validates the patient's feelings and encourages her to share her perspective without feeling judged.
Exploring the patient's underlying symptom (depression/grief) aligns with patient-centered care and creates a foundation for shared decision-making regarding safer pharmacological alternatives.

Anahtar Kavram

Patient-centered communication and empathetic exploration are essential first steps when counseling defensive or resistant patients regarding dangerous health behaviors.
Tahmini Süre:1m 30s
Soru 2765Soru →

A 62-year-old man is evaluated in the surgical intensive care unit. He was admitted 66 days ago following an emergency exploratory laparotomy and small bowel resection for mesenteric ischemia. Postoperatively, he developed a deep vein thrombosis in his right lower extremity and was started on a continuous intravenous unfractionated heparin infusion.

The patient's target activated partial thromboplastin time (aPTT) is 60−8060-80 seconds. His daily laboratory trends are shown below:

Hospital DayPlatelet count (/mm3/\text{mm}^3)aPTT (seconds)
Day 1 (Baseline)320,000320,0002828
Day 2290,000290,0005050
Day 4210,000210,0006565
Day 6 (Today)145,000145,0005252

Today, the patient reports mild worsening of his right leg pain. Vital signs are temperature 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure 135/82135/82 mmHg, heart rate 9292/min, and respirations 1616/min. Physical examination shows persistent right calf swelling and a new area of erythema and induration at a recent peripheral intravenous catheter site.

Based on the clinical and laboratory monitoring parameters provided, which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Discontinue unfractionated heparin and initiate an argatroban infusion

Cevap

Discontinue unfractionated heparin and initiate an argatroban infusion
This patient has developed Heparin-Induced Thrombocytopenia (HIT) Type II. The diagnosis is strongly suggested by the '4Ts': Thrombocytopenia (a drop of >50% from the baseline of 320,000/mm3320,000/\text{mm}^3 to 145,000/mm3145,000/\text{mm}^3), Timing (onset between days 5-10 of heparin therapy), Thrombosis (suspected new thrombosis at the IV site causing erythema and induration, and worsening leg pain), and no oTher obvious causes. When a patient has a high clinical probability of HIT, all heparin-containing products (including unfractionated heparin flushes) must be discontinued immediately. Due to the paradoxically high risk of life-threatening thrombosis (e.g., stroke, myocardial infarction, limb ischemia), the patient requires immediate therapeutic anticoagulation with a non-heparin alternative, most commonly a direct thrombin inhibitor such as argatroban or bivalirudin, or fondaparinux.

Adım Adım Çözüm

1
Analyze the laboratory trends specifically looking at the platelet count relative to baseline, not just the absolute values.
The platelet count dropped from 320,000/mm3320,000/\text{mm}^3 to 145,000/mm3145,000/\text{mm}^3.
Recognizing a relative drop of >50%>50\% is essential, even if the absolute nadir (145,000145,000) is only marginally below the normal reference range.
2
Evaluate the clinical timeline and findings to calculate a 4T score for Heparin-Induced Thrombocytopenia (HIT).
The patient scores high on the 4T scale: >50%>50\% platelet drop (22 points), onset on Day 66 (22 points), new possible thrombosis at the IV site/worsening leg pain (22 points), and no other obvious cause for thrombocytopenia (22 points).
A high 4T score indicates a high pretest probability of HIT, necessitating immediate clinical action.
3
Determine the appropriate empiric treatment modifications for highly suspected HIT.
All heparin products must be immediately discontinued, and an alternative non-heparin anticoagulant (such as the direct thrombin inhibitor argatroban) must be initiated.
Continuing heparin or switching to LMWH will fuel the prothrombotic state. Delaying treatment for confirmatory testing (like an SRA) is contraindicated.

Anahtar Kavram

Monitoring for and managing Heparin-Induced Thrombocytopenia (HIT)
Soru 2766Soru →

Evaluate the clinical presentations below. Match each patient scenario to the most appropriate disposition and care setting transition based on validated risk stratification criteria.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 45-year-old patient with non-exertional chest pain, a normal electrocardiogram, two negative troponin levels, and no history of coronary artery disease
A 68-year-old patient presenting after a syncopal episode, with a history of congestive heart failure and an initial hematocrit of 28%
A 72-year-old patient with community-acquired pneumonia, acute confusion, a respiratory rate of 34/min, and a blood pressure of 85/55 mmHg
A 32-year-old patient with a newly diagnosed segmental pulmonary embolism, normal vital signs, no right heart strain on echocardiogram, and excellent health literacy

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches align each clinical scenario with its guideline-directed care setting using objective risk scores (HEART score, San Francisco Syncope Rule, CURB-65, and PESI).
Each disposition is determined by applying validated clinical risk stratification rules to ensure safe care transitions. Low-risk chest pain and low-risk PE can be managed outpatient, whereas high-risk syncope warrants a ward bed and a CURB-65 of 4 mandates ICU level care.

Adım Adım Çözüm

1
Analyze each patient's clinical variables to calculate their respective risk score (HEART, SFSR, CURB-65, PESI/Hestia criteria).
The risk scores determine if the patient is at low, intermediate, or high risk for short-term adverse outcomes.
Objective risk stratification is required to avoid premature closure and determine the safest, most appropriate level of care.
2
Assign the appropriate care setting transition corresponding to the calculated risk.
Low-risk patients are discharged home with appropriate therapy or follow-up, while higher-risk patients are admitted to the general medical ward or ICU.
Aligning disposition with risk severity optimizes resource utilization and ensures patient safety.

Anahtar Kavram

Application of clinical decision rules (e.g., CURB-65, HEART score, San Francisco Syncope Rule, PESI) to guide safe patient disposition.
Soru 2767Soru →

A 66-year-old biological female presents to the clinic for a routine health maintenance visit. Her past medical history is significant for well-controlled type 2 diabetes mellitus and primary hypertension. Her current medications include metformin and lisinopril. She has never smoked, drinks wine occasionally, and denies illicit drug use. She reports feeling well and has no current complaints.

A review of her medical records reveals the following:
- A screening colonoscopy performed at age 62 was unremarkable.
- A screening mammogram performed 6 months ago was normal.
- Dual-energy x-ray absorptiometry performed at age 65 showed osteopenia with a T-score of −1.4-1.4.
- She has a history of three consecutive normal Papanicolaou (Pap) tests, the most recent being at age 64.
- She received a tetanus, diphtheria, and acellular pertussis (Tdap) booster at age 60 and completed the recombinant zoster vaccine series at age 55.
- She has never received a pneumococcal vaccination.
- There is no record of prior hepatitis screening in her medical chart.

Based on current United States Preventive Services Task Force (USPSTF) and Advisory Committee on Immunization Practices (ACIP) guidelines, which of the following preventive interventions are indicated for this patient at today's visit? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: 20-valent pneumococcal conjugate vaccination; Hepatitis C virus antibody testing

Cevap

The correct interventions are 20-valent pneumococcal conjugate vaccination and Hepatitis C virus antibody testing.
Based on current guidelines, two specific interventions are due for this 66-year-old patient. First, ACIP guidelines dictate that all adults aged 65 and older who have not previously received a pneumococcal conjugate vaccine should receive one (such as PCV20). Second, the USPSTF recommends a one-time screening for hepatitis C virus (HCV) infection for all adults aged 18 to 79 years; because she has no record of this, it is indicated today.

Adım Adım Çözüm

1
Evaluate the patient's age and vaccination history for age-based immunization requirements.
The patient is 66 years old and has never received a pneumococcal vaccine. ACIP recommends PCV20 (or PCV15 followed by PPSV23) for all adults aged 65 and older.
Age is an independent indication for pneumococcal vaccination regardless of comorbidities.
2
Assess the need for routine age-based infectious disease screening.
The patient has no record of prior Hepatitis C testing. USPSTF recommends universal one-time HCV screening for adults aged 18 to 79.
HCV screening relies on a birth cohort/age-based approach rather than solely risk-factor targeting.
3
Review prior screening records to determine if any tests can be safely discontinued.
The patient had her last Pap test at age 64, with three consecutive normal results over the past decade. Because she is now older than 65 and meets the criteria for adequate prior screening, cervical cancer screening should be discontinued.
Continuing Pap testing in low-risk women over 65 provides minimal benefit and increases the risk of false positives and unnecessary procedures.
4
Analyze the patient's social history to determine indications for imaging-based screenings.
The patient has never smoked. Therefore, screening for an abdominal aortic aneurysm (AAA) and lung cancer (via LDCT) are contraindicated/not indicated.
AAA screening is recommended for men aged 65-75 who have ever smoked, and lung cancer screening requires a 20 pack-year smoking history.

Anahtar Kavram

Application of age- and risk-appropriate preventive screening and immunization guidelines (USPSTF and ACIP) in older adults.
Tahmini Süre:1m 30s
Soru 2768Soru →

A 2424-year-old man with a history of type 1 diabetes mellitus is brought to the emergency department with abdominal pain, nausea, and vomiting. Laboratory studies show a serum glucose of 580 mg/dL580 \text{ mg/dL}, bicarbonate of 12 mEq/L12 \text{ mEq/L}, and an anion gap of 2222. He is diagnosed with diabetic ketoacidosis. Assuming his initial serum potassium is 4.5 mEq/L4.5 \text{ mEq/L}, arrange the following management steps in the correct sequential order according to standard treatment protocols.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence for diabetic ketoacidosis management is: 1) Administer rapid IV volume expansion, 2) Initiate continuous IV regular insulin, 3) Add 5% dextrose when glucose falls below 250 mg/dL, 4) Administer subcutaneous basal insulin when the anion gap closes, and 5) Discontinue the IV insulin infusion 1 to 2 hours later.
The established protocol for DKA dictates a strict physiological sequence: circulatory collapse must be prevented first (IV fluids), followed by halting ketogenesis (IV insulin). Because insulin lowers glucose faster than it clears ketones, dextrose must be introduced mid-treatment to allow continued insulin administration without causing hypoglycemia. Finally, resolving the condition requires a transition to subcutaneous insulin, which must overlap with the IV infusion to ensure continuous coverage.

Adım Adım Çözüm

1
Restore intravascular volume using isotonic crystalloid (0.9% normal saline).
Improves blood pressure, tissue perfusion, and facilitates renal clearance of glucose.
Severe dehydration is universally present in diabetic ketoacidosis (DKA). Fluid expansion must be the first step to prevent vascular collapse before insulin shifts fluid intracellularly.
2
Verify potassium is ≥3.3 mEq/L\geq 3.3 \text{ mEq/L} and start continuous IV regular insulin.
Stops ketone production and begins lowering serum glucose.
Insulin drives glucose and potassium into cells. Starting insulin without ensuring adequate potassium can cause life-threatening arrhythmias.
3
Monitor serial chemistries and add dextrose to IV fluids when glucose reaches 200-250 mg/dL200 \text{-} 250 \text{ mg/dL}.
Prevents iatrogenic hypoglycemia.
Glucose normalizes much faster than the ketoacidosis resolves. Insulin must be continued to clear ketones and close the anion gap, so exogenous dextrose is required.
4
Monitor the anion gap and administer subcutaneous insulin once the gap is ≤12\leq 12 and the patient can eat.
Prepares the patient for maintenance off the insulin infusion.
Once the underlying metabolic acidosis is corrected, the patient requires a transition to their long-term home subcutaneous regimen.
5
Wait 11 to 22 hours after the subcutaneous injection, then discontinue the IV insulin.
Completes the transition safely.
Subcutaneous insulin takes time to be absorbed and reach therapeutic blood levels. Stopping the drip simultaneously with the injection leaves a window with no insulin coverage, risking immediate rebound DKA.

Anahtar Kavram

The standard sequence of diabetic ketoacidosis (DKA) management involves initial fluid resuscitation, insulin therapy with careful potassium monitoring, addition of dextrose to prevent hypoglycemia while closing the anion gap, and a safe transition to subcutaneous insulin with appropriate overlap.
Soru 2769Soru →

Match each patient presentation to the single most appropriate next step in preventive care and screening according to current guidelines.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

23-year-old asymptomatic female who is sexually active with a new male partner; previously screened for HIV
52-year-old healthy male presenting for a routine check-up; up to date on routine infectious disease screenings
42-year-old healthy female presenting for a wellness visit, with no family history of cancer; up to date on all blood tests
35-year-old healthy male establishing care; has never undergone any infectious disease screening

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct pairings align the 23-year-old female with chlamydia/gonorrhea screening, the 52-year-old male with the recombinant zoster vaccine, the 42-year-old female with screening mammography, and the 35-year-old male with routine HIV screening.
Each patient precisely meets the age and risk criteria for a specific, highly-tested primary prevention or screening intervention as outlined by the USPSTF and ACIP. Matching these correctly demonstrates baseline competence in routine ambulatory care.

Adım Adım Çözüm

1
Evaluate the 23-year-old female
Identify that she is under 25 and sexually active.
This meets the criteria for routine annual chlamydia and gonorrhea screening.
2
Evaluate the 52-year-old male
Identify that he has crossed the age 50 threshold.
Reaching age 50 is the primary indication to initiate the recombinant zoster vaccination series.
3
Evaluate the 42-year-old female
Identify her as an average-risk female over the age of 40.
Current USPSTF guidelines stipulate initiating biennial screening mammography at age 40.
4
Evaluate the 35-year-old male
Identify that he has never had infectious disease screening.
All adults between 15 and 65 require a one-time HIV screening test.

Anahtar Kavram

Age- and risk-appropriate implementation of core USPSTF and ACIP preventive screening guidelines.
Soru 2770Soru →

An initial primary care evaluation is conducted for a 55-year-old biological female who recently relocated to the area. Her medical background is notable for type 1 diabetes mellitus complicated by end-stage renal disease, requiring hemodialysis three times weekly. She actively smokes and has a 30 pack-year smoking history. Surgically, she underwent a total abdominal hysterectomy ten years ago for symptomatic uterine fibroids. Her preventive care records indicate her last screening mammogram occurred three years ago, and her most recent screening colonoscopy, performed five years ago, was entirely normal. She has not received any vaccinations during the past decade. The patient is compliant with her medications and dialysis regimen. Vital signs and physical examination reveal no acute abnormalities. Which of the following preventive interventions are indicated for this patient today? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Low-dose computed tomography (LDCT) of the chest; Screening mammography; Administration of the 20-valent pneumococcal conjugate vaccine (PCV20)

Cevap

The indicated preventive interventions are low-dose computed tomography of the chest, screening mammography, and administration of the 20-valent pneumococcal conjugate vaccine.
This patient meets the criteria for multiple concurrent preventive interventions. She requires annual low-dose computed tomography (LDCT) of the chest because she is between 50 and 80 years of age, has a 30 pack-year smoking history, and is a current smoker. She is due for screening mammography because the recommended interval is biennial for women aged 40 to 74, and her last examination was three years ago. Furthermore, she should receive the 20-valent pneumococcal conjugate vaccine (PCV20) because adults under 65 with high-risk comorbidities (such as end-stage renal disease, diabetes mellitus, and smoking) require pneumococcal immunization.

Adım Adım Çözüm

1
Evaluate lung cancer screening criteria.
The patient is 55 years old and an active smoker with a 30 pack-year history, meeting the criteria for annual LDCT.
Guidelines recommend annual LDCT for adults aged 50 to 80 with at least a 20 pack-year history who currently smoke or quit within 15 years.
2
Evaluate breast cancer screening criteria.
The patient is a 55-year-old female whose last mammogram was 3 years ago; she requires repeat screening.
Guidelines recommend biennial screening mammography for women aged 40 to 74 years.
3
Evaluate adult immunization needs.
The patient requires the PCV20 vaccine due to her age, smoking status, diabetes, and end-stage renal disease.
Adults aged 19 to 64 with high-risk conditions who have not received pneumococcal vaccines in the past should receive a single dose of PCV20.
4
Evaluate cervical, colorectal, and cardiovascular screening criteria.
Cervical cancer screening is contraindicated due to prior benign hysterectomy. Colonoscopy is premature (due in 5 more years). CAC scanning is not routinely indicated for asymptomatic patients.
Preventive interventions must align with precise time intervals and anatomical history to avoid unnecessary testing and false positives.

Anahtar Kavram

Integration of multiple evidence-based preventive care guidelines based on age, sex, surgical history, and high-risk comorbidities.
Tahmini Süre:2m 30s
Soru 2771Soru →

A 69-year-old man comes to the clinic for a routine health maintenance examination. He has no acute complaints. His medical history includes primary hypertension and gastroesophageal reflux disease, which are well controlled with amlodipine and pantoprazole. He smoked 1 pack of cigarettes daily from age 18 to 50 (32 pack-years) but quit 19 years ago. He drinks alcohol occasionally and does not use illicit drugs. His last colonoscopy was performed at age 63 and showed no polyps or other abnormalities. A hepatitis C virus antibody test was negative three years ago. He received the 2-dose recombinant zoster vaccine series at age 65 and a 20-valent pneumococcal conjugate vaccine (PCV20) at age 66. He received a Tdap booster 4 years ago. Vital signs today are blood pressure 126/78 mm Hg, pulse 70/min, and respirations 14/min. Physical examination is unremarkable. Which of the following is the most appropriate next step in preventive care for this patient?

Cevabı ve açıklamayı göster

Cevap: Ultrasonography of the abdomen

Cevap

Ultrasonography of the abdomen
This patient meets the criteria for abdominal aortic aneurysm (AAA) screening. The United States Preventive Services Task Force (USPSTF) recommends a one-time screening for AAA with ultrasonography of the abdomen in men aged 65 to 75 years who have ever smoked. 'Ever smoked' is defined as having smoked at least 100 cigarettes in a lifetime. This patient is 69 years old and has a 32 pack-year smoking history, making this the most appropriate next step in preventive care.

Adım Adım Çözüm

1
Evaluate the patient's demographics and social history.
The patient is a 69-year-old man with a significant smoking history (32 pack-years).
Age, biological sex, and smoking history dictate specific preventive screening guidelines.
2
Assess the need for lung cancer screening.
Lung cancer screening is not indicated because the patient quit smoking 19 years ago.
Guidelines recommend stopping annual screening once a person has not smoked for 15 years.
3
Determine eligibility for abdominal aortic aneurysm (AAA) screening.
The patient meets criteria for AAA screening.
Men aged 65 to 75 years who have ever smoked should receive a one-time screening ultrasound for AAA.

Anahtar Kavram

The USPSTF recommends a one-time screening for an abdominal aortic aneurysm with ultrasonography in men aged 65 to 75 years who have a history of smoking (at least 100 cigarettes in a lifetime).
Tahmini Süre:1m 15s
Soru 2772Soru →

A 61-year-old woman is evaluated in the hospital for altered mental status. She was admitted 3 days ago for management of acute kidney injury secondary to ureteral obstruction. Her past medical history is significant for advanced cervical cancer, and her severe pelvic pain has been well controlled at home with high-dose extended-release oral morphine.

Today, the patient's partner reports that she has become progressively confused and agitated overnight. On examination, the patient is somnolent but groans and withdraws to light touch, demonstrating severe tactile allodynia. She frequently exhibits involuntary, rapid muscle jerks in all four extremities. Vital signs show a temperature of 37.1°C (98.8°F), blood pressure of 110/70 mmHg, heart rate of 98/min, and respiratory rate of 18/min. Oxygen saturation is 97% on room air. Laboratory studies show a serum creatinine of 3.8 mg/dL (baseline 1.1 mg/dL). Which of the following is the most appropriate next step in the management of this patient's symptoms?

Cevabı ve açıklamayı göster

Cevap: Discontinue morphine, provide intravenous hydration, and rotate to a reduced dose of intravenous fentanyl

Cevap

Discontinue morphine, provide intravenous hydration, and rotate to a reduced dose of intravenous fentanyl
The patient is experiencing opioid-induced neurotoxicity (OIN), characterized by altered mental status, tactile allodynia (hyperalgesia), and myoclonus. This condition frequently occurs when patients on high doses of morphine develop acute kidney injury. Morphine is hepatically metabolized into morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G), which are renally excreted. In acute kidney injury, M3G accumulates and crosses the blood-brain barrier, causing neurotoxic effects. The definitive management of OIN is to discontinue the offending opioid, provide intravenous hydration to promote renal clearance of the metabolites (if the patient's volume status permits), and rotate to a structurally dissimilar opioid. Fentanyl and methadone are the preferred opioids in severe renal impairment because they lack active neurotoxic metabolites that rely on renal clearance. Due to incomplete cross-tolerance, the initial dose of the new opioid should be appropriately reduced.

Adım Adım Çözüm

1
Identify the patient's acute clinical syndrome.
The patient presents with somnolence, tactile allodynia, confusion, and multifocal myoclonic jerks with a normal respiratory rate.
These findings represent the classic triad of opioid-induced neurotoxicity (OIN): hyperalgesia, myoclonus, and delirium.
2
Determine the underlying etiology for the syndrome.
The patient has a severely elevated serum creatinine (3.8 mg/dL) indicating acute kidney injury.
Morphine is hepatically metabolized into active metabolites (morphine-3-glucuronide) that rely on renal clearance. In renal failure, these neurotoxic metabolites accumulate rapidly.
3
Select the appropriate therapeutic intervention.
Discontinue the offending agent (morphine), provide intravenous hydration to facilitate clearance, and rotate to an opioid that is safe in renal impairment (such as fentanyl).
This strategy directly treats the underlying cause (metabolite accumulation) while safely maintaining necessary analgesia.

Anahtar Kavram

Opioid-induced neurotoxicity presents with hyperalgesia, myoclonus, and delirium, frequently triggered by the accumulation of active morphine metabolites (M3G) in the setting of acute kidney injury. Definitive management requires hydration and opioid rotation to a safer alternative like fentanyl or methadone.
Soru 2773Soru →

Seeking guidance on cancer risk reduction, a 38-year-old biological male visits his primary care physician for a wellness check. He feels well and reports no rectal bleeding, weight loss, or change in stool caliber. His only medication is a daily multivitamin. Family history is significant for his mother being diagnosed with adenocarcinoma of the colon when she was 45 years of age. Consistent with high-risk surveillance guidelines, the patient underwent an initial screening colonoscopy three years ago (at age 35); the procedure was entirely normal with no polyps identified. He does not use tobacco or illicit substances. His vital signs and physical examination are within normal limits. Which of the following is the most appropriate management regarding colorectal cancer screening for this patient?

Cevabı ve açıklamayı göster

Cevap: Schedule a screening colonoscopy at age 40

Cevap

Schedule a screening colonoscopy at age 40
The patient is at high risk for colorectal cancer (CRC) because a first-degree relative (his mother) was diagnosed before the age of 60. Current guidelines dictate that such individuals should begin screening at age 40, or 10 years before the relative's diagnosis, whichever comes first. Consequently, this patient correctly had his first colonoscopy at age 35 (10 years prior to 45). For this specific high-risk cohort, the surveillance interval following a normal colonoscopy is every 5 years, unlike the 10-year interval used for average-risk individuals. Therefore, his next screening colonoscopy is due at age 40.

Adım Adım Çözüm

1
Identify the patient's colorectal cancer risk stratification.
The patient is at high risk because he has a first-degree relative (mother) diagnosed with colorectal cancer before age 60.
Family history directly dictates both the initiation age and the required interval for colorectal cancer screening.
2
Verify the correct initiation age for this risk category.
Screening must begin at age 40 or 10 years prior to the relative's diagnosis, whichever is earlier. Since the mother was diagnosed at 45, 10 years prior is 35.
The patient correctly had his first colonoscopy at age 35, establishing a baseline.
3
Determine the appropriate surveillance interval following a normal colonoscopy.
For patients with a first-degree relative diagnosed before age 60, the interval following a normal colonoscopy is every 5 years.
High-risk patients require more frequent structural surveillance than the standard 10-year interval used for average-risk individuals.
4
Calculate the timing for the next screening.
The baseline colonoscopy was at age 35. Adding the 5-year interval means the next colonoscopy is due at age 40.
This establishes that the patient does not need immediate intervention today (at age 38) but should be scheduled at age 40.

Anahtar Kavram

Patients with a first-degree relative diagnosed with colorectal cancer before age 60 must undergo screening colonoscopy starting at age 40 or 10 years prior to the relative's age at diagnosis (whichever is earlier), and the procedure should be repeated every 5 years if normal.
Soru 2774Soru →

A 34-year-old male is evaluated via a telemedicine consultation for follow-up of newly diagnosed type 2 diabetes mellitus. His medical history is significant for ischemic cardiomyopathy resulting in NYHA class III heart failure. Two weeks ago, his hemoglobin A1c was 8.2%, and he was prescribed metformin along with counseling on dietary modifications. Today, the patient states, 'I have not picked up the prescription. I watched a documentary claiming that diabetes medications are highly toxic to the body. Instead, I have decided to cure my condition with a strict 30-day fruit juice cleanse.' Which of the following is the most appropriate initial response by the physician?

Cevabı ve açıklamayı göster

Cevap: Can you share more about the information you found in the documentary regarding diabetes treatments?

Cevap

The most appropriate response is to ask the patient to share more about the information found in the documentary.
The correct answer utilizes open-ended inquiry to understand the patient's perspective. When dealing with medication nonadherence or belief in medical misinformation, the physician must first explore the patient's fears and understanding. Telling the patient they are wrong, ignoring their concerns, or immediately offering alternatives bypasses the patient's autonomy and can severely damage the physician-patient relationship. Exploring what they learned from the documentary builds trust and allows the physician to subsequently provide targeted, respectful education.

Adım Adım Çözüm

1
Analyze the patient's statement and underlying emotion.
The patient is expressing fear and skepticism about conventional medication based on misinformation, and prefers a potentially harmful dietary approach (juice cleanse).
Identifying the patient's stance helps determine their stage of readiness and the barriers to medication adherence.
2
Identify the goal of the physician's immediate response.
The initial goal is to maintain the therapeutic alliance, gather more information about the patient's beliefs, and avoid triggering defensiveness.
Directly challenging the patient, threatening them with capacity evaluations, or abruptly changing the subject will likely cause the patient to disengage from care entirely.
3
Select the communication strategy that best achieves this goal.
Using an open-ended question to explore the patient's source of information validates their autonomy and opens the door for targeted, respectful education.
Exploring the patient's beliefs is a core tenet of motivational interviewing and effective patient counseling.

Anahtar Kavram

When addressing patients who hold medically inaccurate beliefs or refuse recommended therapies, the initial step is to use open-ended exploration to understand their perspective and build rapport, rather than immediately correcting, threatening, or changing the subject.
Tahmini Süre:1m 0s
Soru 2775Soru →

A palliative care attending physician at a tertiary medical center is reviewing several patient charts to formulate targeted recommendations for symptom control and care transitions. Match each of the following clinical scenarios with the most appropriate next step in palliative or end-of-life management.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A patient with advanced bone metastases on high-dose morphine develops severe myoclonus, hyperalgesia, and worsening renal function.
A patient with end-stage chronic obstructive pulmonary disease and frequent exacerbations who wishes to forgo future hospitalizations and focus solely on comfort at home.
A patient with terminal amyotrophic lateral sclerosis experiencing severe, refractory agitated delirium and dyspnea unresponsive to aggressive opioid and haloperidol titration.
An actively dying patient in an inpatient hospice setting who develops loud, gurgling respiratory secretions that are distressing to the family.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches align specific palliative challenges with their targeted interventions: opioid neurotoxicity requires opioid rotation; the desire for exclusive home comfort care requires home hospice enrollment; refractory terminal suffering requires palliative sedation; and terminal respiratory secretions require anticholinergics.
Each clinical scenario presents a classic presentation of a palliative care challenge. Recognizing opioid neurotoxicity prompts opioid rotation; respecting a patient's wish for exclusive home comfort care prompts hospice enrollment; encountering refractory terminal symptoms prompts palliative sedation; and observing terminal respiratory secretions prompts the use of drying anticholinergic agents.

Adım Adım Çözüm

1
Identify the primary underlying etiology or the primary goal of care in each clinical scenario.
Scenario 1 involves opioid neurotoxicity driven by renal failure; Scenario 2 involves a transition from aggressive care to comfort care at home; Scenario 3 involves refractory terminal symptoms; Scenario 4 involves excess terminal respiratory secretions.
Accurate identification of the underlying palliative care issue dictates the specific therapeutic or logistical intervention required.
2
Select the appropriate pharmacological or systems-based intervention for each identified issue.
Morphine toxicity in renal failure is treated with fentanyl or methadone. The desire for comfort care at home is best achieved via a hospice program. Refractory terminal suffering warrants palliative sedation. The death rattle is treated with anticholinergic agents.
These interventions represent evidence-based, standard-of-care practices in palliative medicine.

Anahtar Kavram

Appropriate evidence-based management of end-of-life symptoms and care transitions.
Soru 2776Soru →

A 54-year-old woman is evaluated for discharge planning on hospital day 14. She was initially admitted to the intensive care unit for severe acute pancreatitis complicated by acute respiratory distress syndrome, which required mechanical ventilation for 7 days. She was successfully extubated 4 days ago and transferred to the general medical floor. The patient is awake, alert, and oriented. Vital signs are within normal limits. Oxygen saturation is 96% on room air. She is tolerating an oral diet, and her pain is well controlled with oral analgesics. All invasive lines and drains have been removed.

Physical and occupational therapy evaluation reveals profound ICU-acquired weakness. The patient requires maximum assistance for bed-to-chair transfers and is unable to bear weight independently. During her evaluation, she becomes easily fatigued and can actively participate in therapy for only 30 to 45 minutes daily before requiring extended rest. Prior to her hospitalization, she lived alone in a single-family home. Her immediate family lives nearby but they work full-time and cannot provide around-the-clock care.

Which of the following is the most appropriate disposition for this patient?

Cevabı ve açıklamayı göster

Cevap: Skilled nursing facility

Cevap

The correct answer is a skilled nursing facility, as the patient is medically stable but requires slower-paced, daily skilled rehabilitation that she can tolerate.
The correct answer is a skilled nursing facility. This patient requires daily skilled physical and occupational therapy due to profound ICU-acquired weakness. However, she currently lacks the endurance to participate in 3 hours of intensive therapy per day, tolerating only 30-45 minutes. A skilled nursing facility is the most appropriate setting because it provides necessary medical supervision and a slower-paced rehabilitation program tailored to patients who cannot tolerate the rigorous demands of an inpatient rehabilitation facility.

Adım Adım Çözüm

1
Assess the patient's current medical stability and need for ongoing physician intervention.
The patient is medically stable, successfully extubated, tolerating an oral diet, and requires only oral medications.
Determining medical stability differentiates the need for continued acute care (like a long-term acute care hospital) from post-acute care rehabilitation settings.
2
Evaluate the patient's functional status, physical therapy needs, and endurance capacity.
The patient requires maximum assistance for transfers and can only tolerate 30 to 45 minutes of therapy per day due to profound fatigue.
Therapy tolerance is the primary differentiator between an inpatient rehabilitation facility, which requires a minimum of 3 hours of daily therapy, and a skilled nursing facility, which accommodates lower endurance.
3
Assess the patient's social support and home environment to determine if a home discharge is safe.
The patient lives alone and her family members work full-time, meaning she would lack necessary daytime physical assistance.
Patients requiring maximum assistance for mobility cannot be safely discharged home without 24-hour caregiver support.
4
Synthesize medical, functional, and social data to select the most appropriate care setting.
A skilled nursing facility is selected.
It provides the required daily skilled rehabilitation at a slower pace the patient can tolerate, along with a safe environment and nursing care.

Anahtar Kavram

Post-acute care disposition depends heavily on medical acuity and rehabilitation tolerance. Medically stable patients needing multidisciplinary rehabilitation who can tolerate at least 3 hours of daily therapy qualify for an inpatient rehabilitation facility (IRF), whereas those needing a slower-paced recovery belong in a skilled nursing facility (SNF).
Soru 2777Soru →

A patient who recently turned 65 years old presents to establish care at a new primary care practice. His past medical history is unremarkable, and he takes no medications. He mentions that he has smoked one pack of cigarettes per day since he was 25 years old and continues to smoke. He feels well and denies any respiratory symptoms, changes in bowel habits, or abdominal pain. He has not seen a physician in over 15 years and has never undergone any formal health maintenance screenings. Based on current guidelines, which of the following preventive interventions are strongly indicated for this patient? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Annual screening for lung cancer with a non-contrast chest CT; One-time screening for abdominal aortic aneurysm via abdominal ultrasound; Colorectal cancer screening with a stool-based test or endoscopy

Cevap

The indicated preventive screenings for this patient are annual screening for lung cancer with a non-contrast chest CT, a one-time screening for an abdominal aortic aneurysm via abdominal ultrasound, and colorectal cancer screening with a stool-based test or endoscopy.
The correct interventions are based directly on current USPSTF guidelines. Annual lung cancer screening with a non-contrast chest CT is indicated for adults aged 50 to 80 years with at least a 20 pack-year smoking history who currently smoke or quit within the last 15 years. A one-time abdominal ultrasound for abdominal aortic aneurysm screening is indicated for men aged 65 to 75 who have ever smoked. Finally, colorectal cancer screening is universally recommended for all average-risk adults between the ages of 45 and 75.

Adım Adım Çözüm

1
Evaluate the patient's demographics and smoking history to determine lung cancer screening eligibility.
The patient is 65 years old with a 40 pack-year smoking history.
The USPSTF recommends annual lung cancer screening with low-dose CT for adults aged 50-80 with at least a 20 pack-year smoking history who currently smoke or quit within the past 15 years.
2
Assess the need for abdominal aortic aneurysm (AAA) screening based on age, sex, and smoking history.
The patient is a 65-year-old male who has a history of smoking.
The USPSTF recommends a one-time screening for AAA with ultrasonography in men aged 65-75 years who have ever smoked.
3
Determine the indication for colorectal cancer (CRC) screening.
The patient is 65 years old and has never been screened.
The USPSTF recommends CRC screening for all average-risk adults aged 45-75 years.
4
Review the indications for the remaining choices to rule them out.
Bone densitometry and screening electrocardiograms are not routinely recommended for this demographic.
Osteoporosis screening is primarily indicated for females over 65 or high-risk younger females, and routine electrocardiogram screening is not recommended in asymptomatic, low-risk adults.

Anahtar Kavram

Age- and risk-based preventive screening guidelines for older adults
Soru 2778Soru →

A 28-year-old man recently diagnosed with HIV infection returns to the clinic to discuss his laboratory results. His CD4 cell count is 650/mm³ and his HIV viral load is 45,000 copies/mL. He is currently asymptomatic and has no other medical conditions. During the visit, the physician recommends initiating daily antiretroviral therapy (ART). The patient crosses his arms, shakes his head, and says, "I have been reading a lot online, and I decided I am not going to take those toxic chemicals. I feel perfectly fine right now. I will only consider taking them if my immune system actually starts failing and I get sick." Which of the following is the most appropriate initial response by the physician?

Cevabı ve açıklamayı göster

Cevap: It is understandable that you want to avoid toxicities. Can you tell me more about the specific side effects you are most concerned about?

Cevap

The most appropriate response is to validate the patient's concerns and ask an open-ended question to explore specific fears about medication side effects.
The initial step in patient counseling and health education, especially when encountering treatment refusal or hesitancy, is to explore the patient's underlying illness representation and specific fears. This patient-centered approach builds a therapeutic alliance and identifies the exact educational gaps that need to be addressed. Using open-ended questions to explore concerns about medication toxicity validates the patient's autonomy while gathering necessary information to provide targeted education in the subsequent steps of the interview.

Adım Adım Çözüm

1
Analyze the patient's statement and emotional state.
The patient is asymptomatic, hesitant to start ART due to fear of "toxic chemicals," and believes treatment is only necessary for symptomatic disease.
Understanding the patient's perspective and illness representation is required before implementing any educational or therapeutic intervention.
2
Evaluate clinical and ethical constraints.
The patient is an adult who appears to have decision-making capacity. Coercion, threats of mandatory reporting, or paternalistic demands are ethically prohibited and counterproductive.
Maintaining the therapeutic alliance while respecting patient autonomy is the standard of care in outpatient counseling.
3
Select the best communication strategy.
Choose a response that validates the patient's concern without agreeing with incorrect facts, and ask an open-ended question to gather more information.
This approach reduces defensiveness and facilitates targeted health education and collaborative decision-making.

Anahtar Kavram

Patient-centered counseling and exploring illness beliefs
Soru 2779Soru →

Review the following patient presentations from today's primary care clinic. For each patient, select the single most appropriate next step in preventive care based on current United States Preventive Services Task Force (USPSTF) guidelines.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 66-year-old male patient with a 40 pack-year smoking history, currently smoking. He is up to date on colonoscopy, annual low-dose chest CT, and lipid panel testing. No previous imaging of the abdomen has been recorded.
An active, healthy 66-year-old female who has never smoked. Her records indicate recent normal results for screening mammography, colonoscopy, and routine metabolic blood work.
A 52-year-old woman who previously smoked 1 pack per day for 15 years before quitting 20 years ago. She had a normal colonoscopy and cervical cytology two years ago. Her most recent breast imaging was completed at age 48.
An asymptomatic 24-year-old female patient who is sexually active with a new male partner. She has never smoked. A routine cervical cytology test performed 6 months ago was normal.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Match the 66-year-old male to one-time abdominal ultrasonography, the 66-year-old female to dual-energy x-ray absorptiometry, the 52-year-old woman to screening mammography, and the 24-year-old female to nucleic acid amplification testing for Chlamydia trachomatis.
Each patient accurately fulfills a specific, evidence-based USPSTF Grade A or B recommendation for screening interventions based on their exact combination of biological sex, age, and risk exposures.

Adım Adım Çözüm

1
Evaluate the 66-year-old male patient's risk profile.
He requires AAA screening.
He falls into the 65-75 age range for men and has a positive smoking history, meeting the criteria for a one-time abdominal ultrasound.
2
Assess the healthy 66-year-old female patient.
She requires osteoporosis screening.
All women aged 65 and older meet the age-based criteria for a screening DEXA scan, regardless of other risk factors.
3
Review the history of the 52-year-old woman with a remote smoking history.
She requires screening mammography.
She is due for her biennial mammogram. Her smoking history (15 pack-years, quit 20 years ago) falls short of the current criteria for LDCT lung cancer screening.
4
Analyze the preventive needs of the 24-year-old sexually active female.
She requires Chlamydia screening.
She is up to date on her cervical cytology (Pap smear), but current guidelines mandate STI screening (Chlamydia and Gonorrhea) for sexually active women aged 24 and younger.

Anahtar Kavram

Age, sex, and risk-factor specific preventive screening modalities (USPSTF guidelines).
Soru 2780Soru →

A 42-year-old woman is evaluated in the clinic prior to a change in her medication regimen. She has a 4-year history of seropositive rheumatoid arthritis. For the past year, she has been managed with sulfasalazine and hydroxychloroquine, but she reports persistent morning stiffness lasting over two hours and increasing pain in her wrists and hands. Examination shows synovitis with effusions in the bilateral wrists, metacarpophalangeal joints, and proximal interphalangeal joints. Radiographs of the hands reveal new periarticular erosions. The physician decides to discontinue sulfasalazine and initiate therapy with methotrexate and infliximab. The patient has no history of cardiovascular or liver disease, and her physical examination is otherwise unremarkable. Which of the following baseline screening tests are strictly required before initiating this new pharmacologic regimen? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Interferon-gamma release assay; Hepatitis B surface antigen and core antibody

Cevap

The required baseline screening tests before initiating a TNF-alpha inhibitor and methotrexate are an interferon-gamma release assay (or tuberculin skin test) and hepatitis B surface antigen and core antibody testing.
The correct baseline monitoring parameters for a patient starting a tumor necrosis factor (TNF)-alpha inhibitor (infliximab) and methotrexate include an interferon-gamma release assay (or tuberculin skin test) and hepatitis B surface antigen and core antibody testing. TNF-alpha is essential for maintaining granulomas that sequester Mycobacterium tuberculosis. Inhibiting TNF-alpha greatly increases the risk of reactivating latent tuberculosis infection, making baseline screening mandatory. Furthermore, both methotrexate and TNF-alpha inhibitors are potent immunosuppressants associated with a significant risk of hepatitis B reactivation, which can lead to fulminant hepatic failure. Consequently, all patients must have baseline serologic testing for hepatitis B prior to initiating therapy.

Adım Adım Çözüm

1
Identify the proposed high-risk pharmacotherapy.
The patient is being started on a TNF-alpha inhibitor (infliximab) and a disease-modifying antirheumatic drug (methotrexate).
Different immunosuppressive medications have unique adverse effect profiles and require specific baseline screening protocols.
2
Determine the infectious disease screening requirements for TNF-alpha inhibitors.
TNF-alpha inhibitors require baseline screening for latent tuberculosis and hepatitis B due to the high risk of fatal reactivation.
TNF-alpha is crucial for granuloma maintenance (preventing tuberculosis dissemination) and viral clearance.
3
Evaluate the need for other proposed screening tests based on patient factors and drug mechanisms.
Routine echocardiography, TPMT testing, and ANA/anti-dsDNA screening are not indicated for this specific drug combination in an asymptomatic patient.
Screening must be evidence-based and directly tailored to the specific risks of the prescribed medications, avoiding unnecessary testing based on unrelated contraindications.

Anahtar Kavram

Prior to initiating TNF-alpha inhibitors (e.g., infliximab) and methotrexate, patients must undergo baseline screening for latent tuberculosis (via IGRA or tuberculin skin test) and hepatitis B (via surface antigen and core antibody testing) to prevent severe disease reactivation.
ÖncekiSayfa 139 / 237Sonraki